Bian Jiaxiang, Wang Xiaoyang, Hao Wei, Zhang Guangjian, Wang Yuting
School of Clinical Medicine, Weifang Medical University, Weifang, China.
Department of Neurosurgery, Weifang People's Hospital, Weifang, China.
Front Aging Neurosci. 2023 Jul 6;15:1199826. doi: 10.3389/fnagi.2023.1199826. eCollection 2023.
In recent years, radiomics has been increasingly utilized for the differential diagnosis of Parkinson's disease (PD). However, the application of radiomics in PD diagnosis still lacks sufficient evidence-based support. To address this gap, we carried out a systematic review and meta-analysis to evaluate the diagnostic value of radiomics-based machine learning (ML) for PD.
We systematically searched Embase, Cochrane, PubMed, and Web of Science databases as of November 14, 2022. The radiomics quality assessment scale (RQS) was used to evaluate the quality of the included studies. The outcome measures were the c-index, which reflects the overall accuracy of the model, as well as sensitivity and specificity. During this meta-analysis, we discussed the differential diagnostic value of radiomics-based ML for Parkinson's disease and various atypical parkinsonism syndromes (APS).
Twenty-eight articles with a total of 6,057 participants were included. The mean RQS score for all included articles was 10.64, with a relative score of 29.56%. The pooled c-index, sensitivity, and specificity of radiomics for predicting PD were 0.862 (95% CI: 0.833-0.891), 0.91 (95% CI: 0.86-0.94), and 0.93 (95% CI: 0.87-0.96) in the training set, and 0.871 (95% CI: 0.853-0.890), 0.86 (95% CI: 0.81-0.89), and 0.87 (95% CI: 0.83-0.91) in the validation set, respectively. Additionally, the pooled c-index, sensitivity, and specificity of radiomics for differentiating PD from APS were 0.866 (95% CI: 0.843-0.889), 0.86 (95% CI: 0.84-0.88), and 0.80 (95% CI: 0.75-0.84) in the training set, and 0.879 (95% CI: 0.854-0.903), 0.87 (95% CI: 0.85-0.89), and 0.82 (95% CI: 0.77-0.86) in the validation set, respectively.
Radiomics-based ML can serve as a potential tool for PD diagnosis. Moreover, it has an excellent performance in distinguishing Parkinson's disease from APS. The support vector machine (SVM) model exhibits excellent robustness when the number of samples is relatively abundant. However, due to the diverse implementation process of radiomics, it is expected that more large-scale, multi-class image data can be included to develop radiomics intelligent tools with broader applicability, promoting the application and development of radiomics in the diagnosis and prediction of Parkinson's disease and related fields.
https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=383197, identifier ID: CRD42022383197.
近年来,放射组学越来越多地用于帕金森病(PD)的鉴别诊断。然而,放射组学在PD诊断中的应用仍缺乏充分的循证支持。为填补这一空白,我们进行了一项系统评价和荟萃分析,以评估基于放射组学的机器学习(ML)对PD的诊断价值。
我们系统检索了截至2022年11月14日的Embase、Cochrane、PubMed和Web of Science数据库。使用放射组学质量评估量表(RQS)评估纳入研究的质量。结果指标为c指数,其反映模型的总体准确性,以及敏感性和特异性。在这项荟萃分析中,我们讨论了基于放射组学的ML对帕金森病和各种非典型帕金森综合征(APS)的鉴别诊断价值。
纳入28篇文章,共6057名参与者。所有纳入文章的平均RQS评分为10.64,相对评分为29.56%。在训练集中,放射组学预测PD的合并c指数、敏感性和特异性分别为0.862(95%CI:0.833-0.891)、0.91(95%CI:0.86-0.94)和0.93(95%CI:0.87-0.96),在验证集中分别为0.871(95%CI:0.853-0.890)、0.86(95%CI:0.81-0.89)和0.87(95%CI:0.83-0.91)。此外,在训练集中,放射组学区分PD与APS的合并c指数、敏感性和特异性分别为0.866(95%CI:0.843-0.889)、0.86(95%CI:0.84-0.88)和0.80(95%CI:0.75-0.84),在验证集中分别为0.879(95%CI:0.854-0.903)、0.87(95%CI:0.85-0.89)和0.82(95%CI:0.77-0.86)。
基于放射组学的ML可作为PD诊断的潜在工具。此外,它在区分帕金森病与APS方面表现出色。当样本数量相对充足时,支持向量机(SVM)模型表现出出色的稳健性。然而,由于放射组学的实施过程多样,期望纳入更多大规模、多类别的图像数据,以开发具有更广泛适用性的放射组学智能工具,促进放射组学在帕金森病诊断和预测及相关领域的应用和发展。
https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=383197,标识符ID:CRD42022383197。